2017 ESC Guidelines for the management of acute myocardial ... · What is new in 2017 Guidelines on...

43
2017 ESC Guidelines for the Management of AMI-STEMI (European Heart Journal 2017 - doi:10.1093/eurheartj/ehx095) www.escardio.org/guidelines The Task Force for the management of acute myocardial infarc6on in pa6ents presen6ng with ST-segment eleva6on of the European Society of Cardiology 2017 ESC Guidelines for the management of acute myocardial infarcNon in paNents presenNng with ST-segment elevaNon Chairpersons: Borja Ibanez (Spain), Stefan James (Sweden). Authors/Task Force Members: Stefan Agewall (Norway), Manuel J. Antunes (Portugal), Chiara Bucciarelli-Ducci (UK), Héctor Bueno (Spain), Alida L. P. Caforio (Italy), Filippo Crea (Italy), John A. Goudevenos (Greece), Sigrun Halvorsen (Norway), Gerhard Hindricks (Germany), Adnan Kastra6 (Germany), MaSe J. Lenzen (The Netherlands), Eva PrescoT (Denmark), Marco Roffi (Switzerland), Marco Valgimigli (Switzerland), Christoph Varenhorst (Sweden), Pascal Vranckx (Belgium), Petr Widimský (Czech Republic). 1

Transcript of 2017 ESC Guidelines for the management of acute myocardial ... · What is new in 2017 Guidelines on...

2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)www.escardio.org/guidelines

TheTaskForceforthemanagementofacutemyocardialinfarc6oninpa6entspresen6ngwithST-segmenteleva6onoftheEuropeanSocietyofCardiology

2017ESCGuidelinesforthemanagementofacutemyocardialinfarcNoninpaNentspresenNngwithST-segmentelevaNon

Chairpersons:BorjaIbanez(Spain),StefanJames(Sweden).Authors/TaskForceMembers:StefanAgewall(Norway),ManuelJ.Antunes(Portugal),ChiaraBucciarelli-Ducci(UK),HéctorBueno(Spain),AlidaL.P.Caforio(Italy),FilippoCrea(Italy),JohnA.Goudevenos(Greece),SigrunHalvorsen(Norway),GerhardHindricks(Germany),AdnanKastra6(Germany),MaSeJ.Lenzen(TheNetherlands),EvaPrescoT(Denmark),MarcoRoffi(Switzerland),MarcoValgimigli(Switzerland),ChristophVarenhorst(Sweden),PascalVranckx(Belgium),PetrWidimský(CzechRepublic).

1

2

ESC

WG - Cardiovascular Pharmacotherapy

WG - Cardiovascular Surgery

EACVI - European Association of Cardiovascular Imaging

ACCA - Acute Cardiovascular Care Association

HFA - Heart Failure Association

EHRA - European Heart Rhythm Association

Council - Cardiovascular Nursing and Allied Professions

EAPCI - European Association of PCI

WG - Myocardial and Pericardial Diseases

WG - Thrombosis

EAPC -- European Association of Preventive cardiology

Council – for Cardiology practice

v

vv30 Reviewers

v

v

vv

vv

v

v v

v

v

v

vv

v

v

v

v

v

v

v

v

v

vv

v

v

v

-1224 comments and requests

v

Task Force Members

2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)www.escardio.org/guidelines

19 Authors ESC

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Levelofevidence

3

21%

159 recommendations based on 477 references

A

B

C

3723%

4428%

7849%

A Dataderivedfrommul6plerandomizedclinicaltrialsormeta-analyses.

BDataderivedfromasinglerandomizedclinicaltrialorlargenon-randomizedstudies.

CConsensusofopinionoftheexpertsand/orsmallstudies,retrospec6vestudies,registries.

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

2017NEW/REVISEDCONCEPTS

STRATEGYSELECTIONANDTIMEDELAYS:• Cleardefini6onoffirstmedicalcontact(FMC).• Defini6onof“6me0”tochoosereperfusionstrategy(i.e.thestrategyclockstartsatthe6meof“STEMIdiagnosis”).

• Selec6onofPCIoverfibrinolysis:whenan6cipateddelayfrom“STEMIdiagnosis”towirecrossingis≤120min.• Maximumdelay6mefrom“STEMIdiagnosis”tobolusoffibrinolysisagentissetin10min.• “Door-to-Balloon”termeliminatedfromguidelines.

ELECTROCARDIOGRAMATPRESENTATION:• Lejandrightbundlebranchblockconsideredequalforrecommendingurgentangiographyifischaemicsymptoms.

TIMELIMITSFORROUTINEOPENINGOFANIRA:• 0-12h(ClassI);12-48h(ClassIIa);>48h(ClassIII).

MINOCAANDQUALITYINDICATORS:• Newchaptersdedicatedtothesetopics.

PATIENTSTAKINGANTICOAGULANTS:• Acuteandchronicmanagementpresented.

TIMETOANGIOGRAPHYAFTERFIBRINOLYSIS:• Timeframeissetin2-24hajersuccessfulfibrinolysis.

Whatisnewin2017GuidelinesonAMI-STEMI

4

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

ModesofpaNentpresentaNon,componentsofischaemicNmeandflowchartforreperfusionstrategyselecNon

TotalischaemicNme

TotalischaemicNme

PaNentdelay EMSdelay

PaNentdelay

Systemdelay

Systemdelay

FMC:EMS<10’

STEMIdiagnosis

<10’

FMC:Non-PCIcentre

<10’

FMC:PCIcentre

PrimaryPCI

strategyReperfusion

(Wirecrossing)

Fibrinolysisstrategy

Reperfusion(Ly6cbolus)

PrimaryPCI

strategyReperfusion

(Wirecrossing)

<90’

<10’

<60’

STEMIdiagnosis

≤120min

>120min

TimetoPCI?

5

Term DefiniNonFMC The6mepointwhenthepa6entis

eitherini6allyassessedbyaphysician,paramedic,nurseorothertrainedEMSpersonnelwhocanobtainandinterprettheECG,anddeliverini6alinterven6ons(e.g.defibrilla6on).FMCcanbeeitherintheprehospitalseSngoruponpa6entarrivalatthehospital(e.g.emergencydepartment).

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

ModesofpaNentpresentaNon,componentsofischaemicNmeandflowchartforreperfusionstrategyselecNon

TotalischaemicNme

TotalischaemicNme

PaNentdelay EMSdelay

PaNentdelay

Systemdelay

Systemdelay

FMC:EMS<10’

STEMIdiagnosis

<10’

FMC:Non-PCIcentre

<10’

FMC:PCIcentre

PrimaryPCI

strategyReperfusion

(Wirecrossing)

Fibrinolysisstrategy

Reperfusion(Ly6cbolus)

PrimaryPCI

strategyReperfusion

(Wirecrossing)

<90’

<10’

<60’

STEMIdiagnosis

≤120min

>120min

TimetoPCI?

9

Term DefiniNonSTEMIdiagnosis

The6meatwhichtheECGofapa6entwithischaemicsymptomsisinterpretedaspresen6ngST-segmenteleva6onorequivalent.

Ambiguoustermsareeliminated:“Door-to-balloon”“Doortodoor”

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

ModesofpaNentpresentaNon,componentsofischaemicNmeandflowchartforreperfusionstrategyselecNon

TotalischaemicNme

TotalischaemicNme

PaNentdelay EMSdelay

PaNentdelay

Systemdelay

Systemdelay

FMC:EMS<10’

STEMIdiagnosis

<10’

FMC:Non-PCIcentre

<10’

FMC:PCIcentre

PrimaryPCI

strategyReperfusion

(Wirecrossing)

Fibrinolysisstrategy

Reperfusion(Ly6cbolus)

PrimaryPCI

strategyReperfusion

(Wirecrossing)

<90’

<10’

<60’

STEMIdiagnosis

≤120min

>120min

TimetoPCI?

10

Lejandrightbundlebranchblockareconsideredequalforrecommendingurgentangiographyifischaemic

symptoms.

AtypicalECGpresentaNons§  Bundlebranchblock,§  Ventricularpacing,§  Hyper-acuteTwaves,§  Isolateddepressioninanteriorleads,§  UniversalSTdepressionwithaVRelevaNonIn

Inthepresenceofsymptoms,aprimaryPCI

strategy(urgentangiographyandPCIif

indicated)shouldbefollowed.

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

ModesofpaNentpresentaNon,componentsofischaemicNmeandflowchartforreperfusionstrategyselecNon

TotalischaemicNme

TotalischaemicNme

PaNentdelay EMSdelay

PaNentdelay

Systemdelay

Systemdelay

FMC:EMS<10’

STEMIdiagnosis

<10’

FMC:Non-PCIcentre

<10’

FMC:PCIcentre

PrimaryPCI

strategyReperfusion

(Wirecrossing)

Fibrinolysisstrategy

Reperfusion(Ly6cbolus)

PrimaryPCI

strategyReperfusion

(Wirecrossing)

<90’

<10’

<60’

STEMIdiagnosis

≤120min

>120min

TimetoPCI?

11

IntheabsenceofST-segmentelevaNon Class Level

AprimaryPCIstrategyisindicatedinpa6entswithsuspectedongoingischaemicsymptomsif:‒  haemodynamicinstabilityorcardiogenicshock,‒  recurrentorongoingchestpainrefractorytomedicaltreatment,‒  life-threateningarrhythmiasorcardiacarrest,‒ mechanicalcomplica6onsofmyocardialinfarc6on,‒  acuteheartfailure,‒  recurrentdynamicST-segmentorT-wavechanges,par6cularlywithintermiTentST-segmenteleva6on.

I C

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Reperfusionstrategiesintheinfarct-relatedarteryaccordingtoNmefromsymptomsonset

Early

pha

seofS

TEMI

3hours

Symptomsonset

0 PrimaryPCI

PrimaryPCI

Fibrinolysis(onlyifPCIcannotbeperformed

within120minfromSTEMIdiagnosis)

Fibrinolysis(onlyifPCIcannotbeperformed

within120minfromSTEMIdiagnosis)

I A I A

I AI A

12

12hours

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Reperfusionstrategiesintheinfarct-relatedarteryaccordingtoNmefromsymptomsonset(con&nued)

EvolvedSTEM

I

48hours

Recent

STEM

I

I C

PrimaryPCI(ifsymptoms,

hemodynamicinstabilicy,orarrhythmias)

PrimaryPCI(asymptomaNcstablepaNents)

III ARouNnePCI(asymptomaNcstablepaNents)

IIa B

12hours

13

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

14

CHANGEINRECOMMENDATIONS2012 2017

Same dose i.V in all patients Half dose i.V. in Pts ≥75 years STREAM

Oxygen when SaO2 <95% Oxygen when SaO2 <90% AVOID, DETO2X

Radial access

PRAMI, DANAMI-3-PRIMULTI, CVLPRIT, Compare-Acute

TOTAL, TASTE

MATRIX, HEAT-PPCI

ATOLL, Meta-analysis

Small trials & observational data

EXAMINATION,COMFORTABLE-AMI,NORSTENT

MATRIX

DES over BMS

Complete Revascularization

Thrombus Aspiration

Bivalirudin

Enoxaparin

Early Hospital Discharge

OXYGEN

TNK-tPA

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

15

CHANGEINRECOMMENDATIONS2012 2017

Same dose i.V in all patients Half dose i.V. in Pts ≥75 years STREAM

Oxygen when SaO2 <95% Oxygen when SaO2 <90% AVOID, DETO2X

Radial access

PRAMI, DANAMI-3-PRIMULTI, CVLPRIT, Compare-Acute

TOTAL, TASTE

MATRIX, HEAT-PPCI

ATOLL, Meta-analysis

Small trials & observational data

EXAMINATION,COMFORTABLE-AMI,NORSTENT

MATRIX

DES over BMS

Complete Revascularization

Thrombus Aspiration

Bivalirudin

Enoxaparin

Early Hospital Discharge

OXYGEN

TNK-tPA

Valgimigli et al. Lancet 2015;385:2465-76

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

16

CHANGEINRECOMMENDATIONS2012 2017

Same dose i.V in all patients Half dose i.V. in Pts ≥75 years STREAM

Oxygen when SaO2 <95% Oxygen when SaO2 <90% AVOID, DETO2X

Radial access

PRAMI, DANAMI-3-PRIMULTI, CVLPRIT, Compare-Acute

TOTAL, TASTE

MATRIX, HEAT-PPCI

ATOLL, Meta-analysis

Small trials & observational data

EXAMINATION,COMFORTABLE-AMI,NORSTENT

MATRIX

DES over BMS

Complete Revascularization

Thrombus Aspiration

Bivalirudin

Enoxaparin

Early Hospital Discharge

OXYGEN

TNK-tPA

Sabate et al. Lancet 2012;380:1482-90

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

17

CHANGEINRECOMMENDATIONS2012 2017

Same dose i.V in all patients Half dose i.V. in Pts ≥75 years STREAM

Oxygen when SaO2 <95% Oxygen when SaO2 <90% AVOID, DETO2X

Radial access

PRAMI, DANAMI-3-PRIMULTI, CVLPRIT, Compare-Acute

TOTAL, TASTE

MATRIX, HEAT-PPCI

ATOLL, Meta-analysis

Small trials & observational data

EXAMINATION,COMFORTABLE-AMI,NORSTENT

MATRIX

DES over BMS

Complete Revascularization

Thrombus Aspiration

Bivalirudin

Enoxaparin

Early Hospital Discharge

OXYGEN

TNK-tPA

Engstrometal,Lancet2015

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

18

CHANGEINRECOMMENDATIONS2012 2017

Same dose i.V in all patients Half dose i.V. in Pts ≥75 years STREAM

Oxygen when SaO2 <95% Oxygen when SaO2 <90% AVOID, DETO2X

Radial access

PRAMI, DANAMI-3-PRIMULTI, CVLPRIT, Compare-Acute

TOTAL, TASTE

MATRIX, HEAT-PPCI

ATOLL, Meta-analysis

Small trials & observational data

EXAMINATION,COMFORTABLE-AMI,NORSTENT

MATRIX

DES over BMS

Complete Revascularization

Thrombus Aspiration

Bivalirudin

Enoxaparin

Early Hospital Discharge

OXYGEN

TNK-tPA

Jollyetal,NEJM2015Frobertetal,NEJM2013

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

19

CHANGEINRECOMMENDATIONS2012 2017

Same dose i.V in all patients Half dose i.V. in Pts ≥75 years STREAM

Oxygen when SaO2 <95% Oxygen when SaO2 <90% AVOID, DETO2X

Radial access

PRAMI, DANAMI-3-PRIMULTI, CVLPRIT, Compare-Acute

TOTAL, TASTE

MATRIX, HEAT-PPCI

ATOLL, Meta-analysis

Small trials & observational data

EXAMINATION,COMFORTABLE-AMI,NORSTENT

MATRIX

DES over BMS

Complete Revascularization

Thrombus Aspiration

Bivalirudin

Enoxaparin

Early Hospital Discharge

OXYGEN

TNK-tPA

Valgimiglietal,NEJM2015 Shazadetal,Lancet2014

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

20

CHANGEINRECOMMENDATIONS2012 2017

Same dose i.V in all patients Half dose i.V. in Pts ≥75 years STREAM

Oxygen when SaO2 <95% Oxygen when SaO2 <90% AVOID, DETO2X

Radial access

PRAMI, DANAMI-3-PRIMULTI, CVLPRIT, Compare-Acute

TOTAL, TASTE

MATRIX, HEAT-PPCI

ATOLL, Meta-analysis

Small trials & observational data

EXAMINATION,COMFORTABLE-AMI,NORSTENT

MATRIX

DES over BMS

Complete Revascularization

Thrombus Aspiration

Bivalirudin

Enoxaparin

Early Hospital Discharge

OXYGEN

TNK-tPA

Silvainetal,BMJ2012

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

21

CHANGEINRECOMMENDATIONS2012 2017

Same dose i.V in all patients Half dose i.V. in Pts ≥75 years STREAM

Oxygen when SaO2 <95% Oxygen when SaO2 <90% AVOID, DETO2X

Radial access

PRAMI, DANAMI-3-PRIMULTI, CVLPRIT, Compare-Acute

TOTAL, TASTE

MATRIX, HEAT-PPCI

ATOLL, Meta-analysis

Small trials & observational data

EXAMINATION,COMFORTABLE-AMI,NORSTENT

MATRIX

DES over BMS

Complete Revascularization

Thrombus Aspiration

Bivalirudin

Enoxaparin

Early Hospital Discharge

OXYGEN

TNK-tPA

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

22

CHANGEINRECOMMENDATIONS2012 2017

Same dose i.V in all patients Half dose i.V. in Pts ≥75 years STREAM

Oxygen when SaO2 <95% Oxygen when SaO2 <90% AVOID, DETO2X

Radial access

PRAMI, DANAMI-3-PRIMULTI, CVLPRIT, Compare-Acute

TOTAL, TASTE

MATRIX, HEAT-PPCI

ATOLL, Meta-analysis

Small trials & observational data

EXAMINATION,COMFORTABLE-AMI,NORSTENT

MATRIX

DES over BMS

Complete Revascularization

Thrombus Aspiration

Bivalirudin

Enoxaparin

Early Hospital Discharge

OXYGEN

TNK-tPA

Stubbetal,Circ2015

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

•  CangrelorifP2Y12inhibitorshavenotbeengiven.CHAMPION

•  SwitchtopotentP2Y12inhibitors48hoursajerfibrinolysis.Expertopinion

•  ExtendTicagrelorupto36monthsinhigh-riskpa6ents.PEGASUS-TIMI54

•  Useofpolypilltoincreaseadherence.FOCUS

2017NEWRECOMMENDATIONS•  Addi6onallipidloweringtherapyifLDL>1.8mmol/L(70mg/dL)despiteonmaximumtoleratedsta6ns.IMPROVE-IT,FOURIER

•  Completerevasculariza6onduringindexprimaryPCIinSTEMIpa6entsinshock.Expertopinion

IIIIIbIIaI

•  Rou6neuseofdeferredsten6ng.DANAMI3-DEFER

23

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

•  CangrelorifP2Y12inhibitorshavenotbeengiven.CHAMPION

•  SwitchtopotentP2Y12inhibitors48hoursajerfibrinolysis.Expertopinion

•  ExtendTicagrelorupto36monthsinhigh-riskpa6ents.PEGASUS-TIMI54

•  Useofpolypilltoincreaseadherence.FOCUS

2017NEWRECOMMENDATIONS•  Addi6onallipidloweringtherapyifLDL>1.8mmol/L(70mg/dL)despiteonmaximumtoleratedsta6ns.IMPROVE-IT,FOURIER

•  Completerevasculariza6onduringindexprimaryPCIinSTEMIpa6entsinshock.Expertopinion

IIIIIbIIaI

•  Rou6neuseofdeferredsten6ng.DANAMI3-DEFER

24

BhaTetal,NEJM2013

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

Whatisnewin2017GuidelinesonAMI-STEMI

•  CangrelorifP2Y12inhibitorshavenotbeengiven.CHAMPION

•  SwitchtopotentP2Y12inhibitors48hoursajerfibrinolysis.Expertopinion

•  ExtendTicagrelorupto36monthsinhigh-riskpa6ents.PEGASUS-TIMI54

•  Useofpolypilltoincreaseadherence.FOCUS

2017NEWRECOMMENDATIONS•  Addi6onallipidloweringtherapyifLDL>1.8mmol/L(70mg/dL)despiteonmaximumtoleratedsta6ns.IMPROVE-IT,FOURIER

•  Completerevasculariza6onduringindexprimaryPCIinSTEMIpa6entsinshock.Expertopinion

IIIIIbIIaI

•  Rou6neuseofdeferredsten6ng.DANAMI3-DEFER

25

Bonacaetal,NEJM2015

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)26

“Donotforget”intervenNonsinSTEMIpaNentsundergoingaprimaryPCIstrategy

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

DiagnosNctestflowchartinMINOCA

ACUTEINVESTIGATIONSUSPECTEDSTEMI

Coronarystenosis≥50% UrgentangiographyNoCoronarystenosis≥50%+Fulfilment

universalAMIcriteria

TreatasSTEMI MINOCAAcuteLVwallmoNonassessment(angiogram/echo)

27

www.escardio.org/guidelinesFullTextESCPocketGuidelinesAppandmuchmore…

Ιωάννινα

Λευκάδα

Πρέβεζα

Άρτα

Κέρκυρα

Φιλιάτες

STEMI in NW Greece

Διάρκεια 12 µήνες

(1/10/05 – 31/9/06)

n: 359 (άνδρες

82%) Άφιξη από την έναρξη των συµπτωµάτων

<3 h 201(55%) 3-12 59

>12 99

Primary PCI Athens area

STEMI pPCI patients Time Delays

Thrombolysis 2011 2012 2015 Symptoms – FMC 136,91 min 125,5 min 136 min FMC – needle 62,17 min 65,5 min 36 min pPCI Symptoms – FMC 142,41 min 131,26min 125 min FMC – PCI center 129,11 min 119,21 min 78 min Door – Balloon 53,41 min 53,1 min 55 min FMC – Balloon 182,52 min 172,31 min 133 min

ESCPocketGuidelinesAppAny6me-Anywhere

• AllESCPocketGuidelines• Over140interacNvetools

- Algorithms- Calculators- Charts&Scores

• SummaryCards&EssenNalMessages

• Online&Offline

Learn more on the Guidelines area

HELIOS 2005-6 Eπαναιµάτωση σε STEMI

p PCI9%

Lysis50%

No Rx41%

Mε αιµοδ/εργ. Xωρίς

35% 65%

prPCI 24%

1% Θρ/λυση 43%

54% Kαµµιά 33%

45%

2017ESCGuidelinesforthemanagementofacutemyocardialinfarcNoninpaNentspresenNngwithST-segmentelevaNon

EKAB

Ratio Total PCI/Primary PCI: 2007-2015

8,8%

10,2%

15,5%

23%

25%

20%

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

ClassesofrecommendaNons

9258%38

24%

138%

1610%

I IIa

IIb III

159 recommendations Classes DefiniNon Suggested

wording

ClassI Evidenceand/orgeneralagreementthatagiventreatmentorprocedureisbeneficial,useful,effec6ve.

Recommended/isindicated.

ClassIIa Weightofevidence/opinionisinfavourofusefulness/efficacy.

Shouldbeconsidered.

ClassIIb Usefulness/efficacyislesswellestablishedbyevidence/opinion.

Maybeconsidered.

ClassIII Evidenceorgeneralagreementthatthegiventreatmentorprocedureisnotuseful/effec6ve,andinsomecasesmaybeharmful.

Notrecommended.

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

2017NEW/REVISEDCONCEPTS

STRATEGYSELECTIONANDTIMEDELAYS:• Cleardefini6onoffirstmedicalcontact(FMC).• Defini6onof“6me0”tochoosereperfusionstrategy(i.e.thestrategyclockstartsatthe6meof“STEMIdiagnosis”).

• Selec6onofPCIoverfibrinolysis:whenan6cipateddelayfrom“STEMIdiagnosis”towirecrossingis≤120min.• Maximumdelay6mefrom“STEMIdiagnosis”tobolusoffibrinolysisagentissetin10min.• “Door-to-Balloon”termeliminatedfromguidelines.

ELECTROCARDIOGRAMATPRESENTATION:• Lejandrightbundlebranchblockconsideredequalforrecommendingurgentangiographyifischaemicsymptoms.

TIMELIMITSFORROUTINEOPENINGOFANIRA:• 0-12h(ClassI);12-48h(ClassIIa);>48h(ClassIII).

MINOCAANDQUALITYINDICATORS:• Newchaptersdedicatedtothesetopics.

PATIENTSTAKINGANTICOAGULANTS:• Acuteandchronicmanagementpresented.

TIMETOANGIOGRAPHYAFTERFIBRINOLYSIS:• Timeframeissetin2-24hajersuccessfulfibrinolysis.

Whatisnewin2017GuidelinesonAMI-STEMI

41

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)

ModesofpaNentpresentaNon,componentsofischaemicNmeandflowchartforreperfusionstrategyselecNon

TotalischaemicNme

TotalischaemicNme

PaNentdelay EMSdelay

PaNentdelay

Systemdelay

Systemdelay

FMC:EMS<10’

STEMIdiagnosis

<10’

FMC:Non-PCIcentre

<10’

FMC:PCIcentre

PrimaryPCI

strategyReperfusion

(Wirecrossing)

Fibrinolysisstrategy

Reperfusion(Ly6cbolus)

PrimaryPCI

strategyReperfusion

(Wirecrossing)

<90’

<10’

<60’

STEMIdiagnosis

≤120min

>120min

TimetoPCI?

42

www.escardio.org/guidelines 2017ESCGuidelinesfortheManagementofAMI-STEMI(EuropeanHeartJournal2017-doi:10.1093/eurheartj/ehx095)43

Reperfusionstrategiesintheinfarct-relatedarteryaccordingtoNmefromsymptomsonset